Edwards Lifesciences Corp
EW
62 insider filings · Latest: Oct 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Oct 8 9:24 PM | Daniel J. LippisCVP, TAVR | Sale | 619 | $85.65 | $53.0K | 40,033.91(D) | View → |
| Sep 11, 2026 | Sep 11 11:15 PM | Daniel J. LippisCVP, TAVR | Sale | 619 | $87.51 | $54.2K | 40,033.91(D) | View → |
| Aug 31, 2026 | Aug 31 9:47 PM | Andrew M. DahlSVP, Corporate Controller | Sale | 544 | $91.06 | $49.5K | 14,868.41(D) | View → |
| Aug 31, 2026 | Aug 31 8:15 PM | Dahl Andrew M. | Proposed Sale | 544 | $91.06 | $49.5K | — | View → |
| Aug 28, 2026 | Aug 28 8:32 PM | Annette BrulsCVP, EMEACLA | Sale | 2,644 | $89.98 | $237.9K | 17,984(D) | View → |
| Aug 28, 2026 | Aug 28 8:18 PM | Bruls Annette | Proposed Sale | 2,644 | $89.98 | $237.9K | — | View → |
| Aug 26, 2026 | Aug 26 10:36 PM | Daveen ChopraCVP, TMTT, Surgical & IHFM | Sale | 31,800 | $91.02 | $2.9M | 44,324(D) | View → |
| Aug 26, 2026 | Aug 26 10:00 PM | Wayne MarkowitzCVP, JAPAC | Sale | 1,240 | $91.47 | $113.4K | 20,293.558(D) | View → |
| Aug 26, 2026 | Aug 26 8:02 PM | Markowitz Wayne | Proposed Sale | 1,240 | $91.47 | $113.4K | — | View → |
| Aug 26, 2026 | Aug 26 8:01 PM | Chopra Daveen | Proposed Sale | 31,800 | $91.02 | $2.9M | — | View → |
| Aug 11, 2026 | Aug 11 9:07 PM | Daniel J. LippisCVP, TAVR | Sale | 619 | $92.03 | $57.0K | 40,033.91(D) | View → |
| Aug 11, 2026 | Aug 11 8:07 PM | Lippis Daniel J. | Proposed Sale | 1,857 | $92.03 | $170.9K | — | View → |
| Jul 30, 2026 | Jul 30 9:30 PM | Wayne MarkowitzCVP, JAPAC | Sale | 146.313 | $86.03 | $12.6K | 21,533.558(D) | View → |
| Jul 30, 2026 | Jul 30 8:20 PM | Ullem Scott B. | Proposed Sale | 50,000 | $92.50 | $4.6M | — | View → |
| Jul 30, 2026 | Jul 30 8:19 PM | Markowitz Wayne | Proposed Sale | 147 | $85.63 | $12.6K | — | View → |
| Jul 28, 2026 | Jul 28 11:40 PM | Wayne MarkowitzCVP, JAPAC | Sale | 9,628 | $85.06 | $819.0K | 21,679.871(D) | View → |
| Jul 28, 2026 | Jul 28 8:18 PM | Markowitz Wayne | Proposed Sale | 9,628 | $85.06 | $819.0K | — | View → |
| Jul 27, 2026 | Jul 27 10:59 PM | Bernard J ZovighianDirector, CEO | Sale | 2,920.551 | $83.93 | $245.1K | 8,915.65(I) | View → |
| Jul 27, 2026 | Jul 27 8:08 PM | Zovighian Bernard J | Proposed Sale | 2,921 | $83.92 | $245.1K | — | View → |
| Jul 10, 2026 | Jul 10 9:04 PM | Daniel J. LippisCVP, TAVR | Sale | 619 | $91.70 | $56.8K | 40,033.91(D) | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | Oct 8 9:24 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 619 | $72.68 | 3,095(D) | View → |
| Sep 11, 2026 | Sep 11 11:15 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 619 | $72.68 | 3,714(D) | View → |
| Aug 26, 2026 | Aug 26 10:36 PM | Daveen ChopraCVP, TMTT, Surgical & IHFM | Option Exercise | 31,800 | $72.68 | 0(D) | View → |
| Aug 11, 2026 | Aug 11 9:07 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 619 | $72.68 | 4,333(D) | View → |
| Jul 28, 2026 | Jul 28 11:40 PM | Wayne MarkowitzCVP, JAPAC | Option Exercise | 9,628 | $74.02 | 9,628(D) | View → |
| Jul 9, 2026 | Jul 10 9:11 PM | Theodora MistrasCVP, Chief Financial Officer | Grant/Award | 74,125 | $91.33 | 12,325(D) | View → |
| Jul 10, 2026 | Jul 10 9:04 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 619 | $72.68 | 4,952(D) | View → |
| Jun 30, 2026 | Jul 1 12:01 AM | Daniel J. LippisCVP, TAVR | Option Exercise | 619 | $72.68 | 5,571(D) | View → |
| May 18, 2026 | May 18 9:29 PM | Daniel J. LippisCVP, TAVR | Option Exercise | 620 | $72.68 | 6,190(D) | View → |
| May 11, 2026 | May 12 8:55 PM | Bernard J ZovighianDirector, CEO | Option Exercise | 47,207 | — | 0(D) | View → |
| May 11, 2026 | May 12 8:52 PM | Donald E Bobo JRCVP,Strategy/Corp Development | Option Exercise | 13,457 | — | 0(D) | View → |
| May 11, 2026 | May 12 8:50 PM | Daveen ChopraCVP, TMTT & Surgical | Option Exercise | 13,583 | — | 0(D) | View → |
| May 11, 2026 | May 12 1:59 AM | Scott B. UllemCVP, Chief Financial Officer | Option Exercise | 19,830 | — | 0(D) | View → |
| May 7, 2026 | May 12 1:33 AM | Wayne MarkowitzCVP, JAPAC | Grant/Award | 31,600 | $82.76 | 5,200(D) | View → |
| May 7, 2026 | May 12 1:32 AM | Bernard J ZovighianDirector, CEO | Grant/Award | 289,100 | $82.76 | 43,800(D) | View → |
| May 7, 2026 | May 9 1:17 AM | Donald E Bobo JRCVP,Strategy/Corp Development | Grant/Award | 51,850 | $82.76 | 7,850(D) | View → |
| May 7, 2026 | May 9 1:16 AM | Daniel J. LippisCVP, TAVR | Grant/Award | 47,750 | $82.76 | 7,850(D) | View → |
| May 7, 2026 | May 9 1:16 AM | Andrew M. DahlSVP, Corporate Controller | Grant/Award | 6,745 | $82.76 | 6,745(D) | View → |
| May 7, 2026 | May 9 1:16 AM | Daveen ChopraCVP, TMTT & Surgical | Grant/Award | 58,775 | $82.76 | 9,675(D) | View → |
| May 7, 2026 | May 9 1:15 AM | Annette BrulsCVP, EMEACLA | Grant/Award | 40,350 | $82.76 | 6,650(D) | View → |
Page 1 of 2
Next →